Andrés Cruz-Herranz, MD, PhD

About

As a neurologist and a neuroscientist, my goal is to contribute to the development of protective and repairing therapies that improve the lives of those living with neurological diseases and their families.

Experience

• Senior Medical Director at Ovid Therapeutics
  Apr 2026 - Present · 4 mos

  Epilepsy & Rare diseases (Phase 1, Phase 2)

• Medical Director, Clinical Development at Prilenia
  Jul 2022 - Mar 2026 · 3 yrs 9 mos

  • Huntington, ALS (Phase 2 & 3)

• Associate Medical Director, Early Clinical Development at Denali Therapeutics
  2019 - 2022 · 3 yrs

  · Clinical Lead, LRRK2 (Parkinson's) and TREM2 (Alzheimer's) Programs · Medical Monitor, RIPK1 Program (Alzheimer's & ALS) · ETV:IDS Program (MPS II, Hunter syndrome)

• Clinical Research Fellow, Development Neuroscience at Genentech
  2018 - 2019 · 1 yr

  · Programs: Ocrelizumab in Multiple Sclerosis (Phases 3 & 4); Crenezumab in Alzheimer's (Phase 3)

• Review Editor for Neuro-ophthalmology at Frontiers
  2017 - 2018 · 1 yr